Doctor Jeff on Buprenorphine Treatment –

BioDelivery Sciences Provides Business Update and Summary of Third Quarter …

Filed under: buprenorphine treatment

"This has been a year of remarkable progress, having made key strides with our lead product candidates – BEMA Buprenorphine for the treatment of chronic pain and BNX for the treatment of opioid dependence," said Dr. Mark A. Sirgo, President and Chief …
Read more on Sacramento Bee

More Buprenorphine Treatment Information…

Comments are closed.